BioMarin Pharmaceutical Inc. (FRA:BM8)
Germany · Delayed Price · Currency is EUR 52.20
+1.18 (2.31%)
At close: Jan 8, 2026
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €9.74 billion as of January 9, 2026. Its market cap has decreased by -19.85% in one year.
Market Cap
9.74B
Enterprise Value
8.99B
Revenue
2.64B
Ranking
n/a
PE Ratio
21.95
Stock Price
€52.20
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.74B, an increase of 2,187.54%. That is a compound annual growth rate of 12.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 9.74B | 0.12% |
| Dec 31, 2025 | 9.72B | -19.63% |
| Dec 31, 2024 | 12.10B | -26.36% |
| Dec 29, 2023 | 16.43B | -8.70% |
| Dec 30, 2022 | 18.00B | 26.18% |
| Dec 31, 2021 | 14.26B | 9.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |